These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 3160596)

  • 61. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis.
    Cervo L; Grignaschi G; Samanin R
    Eur J Pharmacol; 1988 Dec; 158(1-2):53-9. PubMed ID: 2975608
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors.
    Gudelsky GA; Koenig JI; Meltzer HY
    Neuropharmacology; 1986 Dec; 25(12):1307-13. PubMed ID: 2951611
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
    Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
    Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.
    Chaouloff F; Baudrie V; Laude D
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):381-4. PubMed ID: 1970616
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance.
    Dourish CT; Hutson PH; Kennett GA; Curzon G
    Appetite; 1986; 7 Suppl():127-40. PubMed ID: 2943219
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA; Martin KF
    Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antagonism of 8-OH-DPAT-induced behaviour in rats.
    Berendsen HH; Broekkamp CL; Van Delft AM
    Eur J Pharmacol; 1990 Oct; 187(1):97-103. PubMed ID: 2148726
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA
    J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
    Gilbert F; Dourish CT; Brazell C; McClue S; Stahl SM
    Psychoneuroendocrinology; 1988; 13(6):471-8. PubMed ID: 2907164
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ventrolateral medullary pressor area: site of hypotensive and sympatho-inhibitory effects of (+/-)8-OH-DPAT in anaesthetized dogs.
    Laubie M; Drouillat M; Dabiré H; Cherqui C; Schmitt H
    Eur J Pharmacol; 1989 Feb; 160(3):385-94. PubMed ID: 2523813
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.
    Nishimura Y
    Br J Pharmacol; 1996 Mar; 117(6):1325-1333. PubMed ID: 8882632
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes.
    Heuring RE; Peroutka SJ
    J Neurosci; 1987 Mar; 7(3):894-903. PubMed ID: 2951504
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion.
    Jenck F; Broekkamp CL; Van Delft AM
    Eur J Pharmacol; 1989 Feb; 161(2-3):219-21. PubMed ID: 2524392
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus.
    Markstein R; Hoyer D; Engel G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):335-41. PubMed ID: 2945992
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes.
    Waeber C; Schoeffter P; Palacios JM; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):595-601. PubMed ID: 2975354
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Brainstem 5-hydroxytrytamine1A binding sites are not down-regulated by agonists which induce tolerance in the rat: myoclonus and other serotonergic behaviors.
    Murthy JN; Pranzatelli MR
    J Recept Res; 1992; 12(3):287-97. PubMed ID: 1387164
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition by 8-hydroxy-2-(di-n-propylamino) tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors.
    Hirose A; Tsuji R; Shimizu H; Tatsuno T; Tanaka H; Kumasaka Y; Nakamura M
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):8-13. PubMed ID: 1969119
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats.
    Vergé D; Daval G; Marcinkiewicz M; Patey A; el Mestikawy S; Gozlan H; Hamon M
    J Neurosci; 1986 Dec; 6(12):3474-82. PubMed ID: 2947981
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism.
    Goodwin GM; De Souza RJ; Wood AJ; Green AR
    Psychopharmacology (Berl); 1986; 90(4):488-93. PubMed ID: 2949333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.